Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.040
+0.030 (2.97%)
Jul 8, 2026, 4:00 PM EDT - Market closed
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $12.08 million as of July 8, 2026. Its market cap has increased by 15.51% in one year.
Market Cap
12.08M
Enterprise Value
-4.37M
1-Year Change
15.51%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $12.08M, a decrease of -25.52%. That is a compound annual growth rate of -2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 12.08M | 6.89% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 12.95M |
| Intensity Therapeutics | 12.92M |
| Lunai Bioworks | 12.79M |
| Moleculin Biotech | 12.38M |
| Exicure | 12.11M |
| Psyence Biomedical | 11.86M |
| BioCardia | 11.55M |
| CytoMed Therapeutics | 11.48M |